Currently out of the existing stock ratings of Do Kim, 216 are a BUY (81.2%), 50 are a HOLD (18.8%).

Do Kim

Work Performance Price Targets & Ratings Chart

Analyst Do Kim, carries an average stock price target met ratio of 59.16% that have a potential upside of 44.93% achieved within 396 days. Previously, Do Kim worked at PIPER SANDLER.

Do Kim’s has documented 530 price targets and ratings displayed on 27 stocks. The coverage was on Healthcare, Consumer Defensive sectors.

Most recent stock forecast was given on IONS, Ionis Pharmaceuticals at 22-Feb-2024.

Wall Street Analyst Do Kim

Analyst best performing recommendations are on AKCA (AKCEA THERAPEUTICS).
The best stock recommendation documented was for IONS (IONIS PHARMACEUTICALS) at 11/7/2016. The price target of $48 was fulfilled within 8 days with a profit of $15.88 (49.44%) receiving and performance score of 61.8.

Average potential price target upside

of $166.32 (89.93%) on BTAI (BIOXCEL THERAPEUTICS).
of $114.74 (72%) on RAPT (RAPT THERAPEUTICS).
of $84.67 (47.53%) on AMGN (AMGEN).

ABCL Abcellera Biologics AFMD Affimed NV AKCA Akcea Therapeutics ALNY Alnylam Pharmaceuticals AMGN Amgen BTAI BioXcel Therapeutics CNST Constellation Pharmaceuticals FATE Fate Therapeutics GILD Gilead Sciences HALO Halozyme Therapeutics IONS Ionis Pharmaceuticals MORF Morphic OBSV ObsEva SA RAPT RAPT Therapeutics REPL Replimune Group RIGL Rigel Pharmaceuticals RTRX Travere Therapeutics SDGR Schrodinger SRRK Scholar Rock Holding Corp TCRR Tcr2 Therapeutics TVTX Travere Therapeutics VBIV VBI Vaccines VRTX Vertex Pharmaceuticals NUVB Nuvation Bio EXEL Exelixis CDXS Codexis TAL TAL Education Group

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Scott Schoenhaus (KEYBANK)